352 related articles for article (PubMed ID: 35797341)
1. Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35.
Qin CX; Norling LV; Vecchio EA; Brennan EP; May LT; Wootten D; Godson C; Perretti M; Ritchie RH
Br J Pharmacol; 2022 Oct; 179(19):4617-4639. PubMed ID: 35797341
[TBL] [Abstract][Full Text] [Related]
2. FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.
Maderna P; Cottell DC; Toivonen T; Dufton N; Dalli J; Perretti M; Godson C
FASEB J; 2010 Nov; 24(11):4240-9. PubMed ID: 20570963
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of the formyl peptide receptor 2 gene.
Simiele F; Recchiuti A; Patruno S; Plebani R; Pierdomenico AM; Codagnone M; Romano M
Biochim Biophys Acta; 2016 Oct; 1859(10):1252-8. PubMed ID: 27424221
[TBL] [Abstract][Full Text] [Related]
4. Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.
Brancaleone V; Dalli J; Bena S; Flower RJ; Cirino G; Perretti M
J Immunol; 2011 Apr; 186(8):4905-14. PubMed ID: 21398608
[TBL] [Abstract][Full Text] [Related]
5. Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2.
Zhuang Y; Wang L; Guo J; Sun D; Wang Y; Liu W; Xu HE; Zhang C
Nat Commun; 2022 Feb; 13(1):1054. PubMed ID: 35217703
[TBL] [Abstract][Full Text] [Related]
6. Airway lipoxin A4/formyl peptide receptor 2-lipoxin receptor levels in pediatric patients with severe asthma.
Gagliardo R; Gras D; La Grutta S; Chanez P; Di Sano C; Albano GD; Vachier I; Montalbano AM; Anzalone G; Bonanno A; Riccobono L; Gjomarkaj M; Profita M
J Allergy Clin Immunol; 2016 Jun; 137(6):1796-1806. PubMed ID: 26971688
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential.
Maciuszek M; Cacace A; Brennan E; Godson C; Chapman TM
Eur J Med Chem; 2021 Mar; 213():113167. PubMed ID: 33486199
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages.
Pierdomenico AM; Recchiuti A; Simiele F; Codagnone M; Mari VC; Davì G; Romano M
J Biol Chem; 2015 Feb; 290(6):3592-600. PubMed ID: 25505240
[TBL] [Abstract][Full Text] [Related]
9. Treating neutrophilic inflammation in COPD by targeting ALX/FPR2 resolution pathways.
Bozinovski S; Anthony D; Anderson GP; Irving LB; Levy BD; Vlahos R
Pharmacol Ther; 2013 Dec; 140(3):280-9. PubMed ID: 23880288
[TBL] [Abstract][Full Text] [Related]
10. Lipoxin A
Gaudin A; Tolar M; Peters OA
Sci Rep; 2018 Jun; 8(1):8921. PubMed ID: 29892010
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM
PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767
[TBL] [Abstract][Full Text] [Related]
12. What formyl peptide receptors, if any, are triggered by compound 43 and lipoxin A4?
Forsman H; Önnheim K; Andreasson E; Dahlgren C
Scand J Immunol; 2011 Sep; 74(3):227-234. PubMed ID: 21535079
[TBL] [Abstract][Full Text] [Related]
13. Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure.
Tourki B; Kain V; Pullen AB; Norris PC; Patel N; Arora P; Leroy X; Serhan CN; Halade GV
Mol Metab; 2020 Jan; 31():138-149. PubMed ID: 31918915
[TBL] [Abstract][Full Text] [Related]
14. Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling.
Bena S; Brancaleone V; Wang JM; Perretti M; Flower RJ
J Biol Chem; 2012 Jul; 287(29):24690-7. PubMed ID: 22610094
[TBL] [Abstract][Full Text] [Related]
15. Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond.
Sánchez-García S; Jaén RI; Fernández-Velasco M; Delgado C; Boscá L; Prieto P
Pharmacol Res; 2023 Nov; 197():106982. PubMed ID: 37925045
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.
Dufton N; Hannon R; Brancaleone V; Dalli J; Patel HB; Gray M; D'Acquisto F; Buckingham JC; Perretti M; Flower RJ
J Immunol; 2010 Mar; 184(5):2611-2619. PubMed ID: 20107188
[TBL] [Abstract][Full Text] [Related]
17. Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function.
Planagumà A; Domenech T; Jover I; Ramos I; Sentellas S; Malhotra R; Miralpeix M
Clin Exp Immunol; 2013 Aug; 173(2):298-309. PubMed ID: 23607720
[TBL] [Abstract][Full Text] [Related]
18. FPR2/ALXR agonists and the resolution of inflammation.
Corminboeuf O; Leroy X
J Med Chem; 2015 Jan; 58(2):537-59. PubMed ID: 25365541
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.
Wan M; Godson C; Guiry PJ; Agerberth B; Haeggström JZ
FASEB J; 2011 May; 25(5):1697-705. PubMed ID: 21307335
[TBL] [Abstract][Full Text] [Related]
20. Macrophage sub-populations and the lipoxin A4 receptor implicate active inflammation during equine tendon repair.
Dakin SG; Werling D; Hibbert A; Abayasekara DR; Young NJ; Smith RK; Dudhia J
PLoS One; 2012; 7(2):e32333. PubMed ID: 22384219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
